ClinicalThought

Share

Program Content

Activities

  • FAQs: Bispecific Antibodies for R/R DLBCL
    Optimizing Bispecific Antibody Therapy for R/R DLBCL: Answers to Frequently Asked Questions
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 18, 2024

    Expires: October 17, 2025

Faculty

cover img faculity

Sherry Adkins, MSN, ANP-C, FAAN

Advanced Practice Provider
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Kathleen Dorritie, MD

Assistant Professor of Medicine
Division of Hematology Oncology
UPMC, University of Pittsburgh
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Clinical Care Options, LLC

Supporters

Supported by an educational grant from Genmab US, Inc.

Genmab US, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner